Drug/Small Molecule:

meloxicam

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve the symptoms of arthritis, primary dysmenorrhea, fever; and as an analgesic, especially where there is an inflammatory component. It is closely related to piroxicam. In Europe it is marketed under the brand names Movalis, Melox, and Recoxa. In North America it is generally marketed under the brand name Mobic. In Latin America, the drug is marketed as Tenaron. Wikipedia (source: Drug Bank)

For the treatment of arthritis and osteoarthritis. (source: Drug Bank)

Anti-inflammatory effects of meloxicam are believed to be due to inhibition of prostaglandin synthetase (cylooxygenase), leading to the inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, inhibition of their synthesis may be associated with the analgesic and antipyretic effects of meloxicam. (source: Drug Bank)

Meloxicam is an nonsteroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Prostaglandins are substances that contribute to inflammation of joints. Meloxicam inhibits prostaglandin synthetase (cylooxygenase 1 and 2) and leads to a decrease of the synthesis of prostaglandins, therefore, inflammation is reduced. (source: Drug Bank)

Take without regard to meals. (source: Drug Bank)

Hepatic (source: Drug Bank)

99.4% (source: Drug Bank)

89% (source: Drug Bank)

LD₅₀, Acute: 84 mg/kg (Rat); Oral 470 mg/kg (Mouse); Oral 320 mg/kg (Rabbit) (source: Drug Bank)

Cc1cnc(s1)NC(=O)C2=C(c3ccccc3S(=O)(=O)N2C)O (source: Drug Bank)